Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Metronomic Oral Vinorelbine in Advanced Breast Cancer
2007-002588-28Phase 2Terminated
- Sponsor
- European Institute of Oncology
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in breast cancer, sponsored by European Institute of Oncology. Primary endpoints: Disease Control Rate, Safety profile and 1 more. Started Jul 2007; status: terminated.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002588-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002588-28.